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Abstract: We propose novel estimators for categorical and continuous treatments
by using an optimal covariate balancing strategy for inverse probability weight-
ing. The resulting estimators are shown to be consistent and asymptotically
normal for causal contrasts of interest, either when the model explaining treat-
ment assignment is correctly specified, or when the correct set of bases for the
outcome models has been chosen and the assignment model is sufficiently rich.
For the categorical treatment case, we show that the estimator attains the semi-
parametric efficiency bound when all models are correctly specified. For the
continuous case, the causal parameter of interest is a function of the treatment
dose. The latter is not parametrized and the estimators proposed are shown to
have bias and variance of the classical nonparametric rate. Asymptotic results
are complemented with simulations illustrating the finite sample properties. Our
analysis of a data set suggests a nonlinear effect of BMI on the decline in self
reported health.
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bound.
1 Introduction
Encouraged by the recent booming development of the causal inference literature, we devise
and study a novel inference tool for categorical and continuous treatments by using covariate
balancing strategies for inverse probability weighting (e.g., Fan et al. 2020, Imai & Ratkovic
2014, Wang & Zubizarreta 2019). Our study is built on the fundemental idea on optimal
covariate balancing of Fan et al. (2020), while we overcome additional methodological and
theoretical challenges.
When estimating a causal effect on an outcome, weighting based on the propensity score
(model for the probability of the treatment given observed pre-treatment covariates) is
often used to construct optimal estimators by an augmentation using fitted models for the
outcome given the covariates. These augmented inverse probability weighting estimators
have robustness properties to the specification of models used, and are locally efficient (e.g.,
Robins & Rotnitzky 1995, Scharfstein et al. 1999). A vast majority of the literature on
causal inference have focused on binary treatments, i.e. where the causal parameter of
interest is a contrast between two treatments. Nevertheless, there is an increasing interest
in multi-valued treatments (e.g., Fong et al. 2018, Kennedy et al. 2017, Yang et al. 2016) as
often encountered in applied work, both in the medical and social sciences. Causal effects
of categorical treatment were formalized by, e.g., Imbens (2000) and Robins (2000), while
Cattaneo (2010) deduced the semiparametric efficiency bound; see also Yang et al. (2016) for
a review. Causal effects of continuous treatments were formalized in, e.g., Robins (2000),
van der Laan & Robins (2003), Hirano & Imbens (2004) and Galvao & Wang (2015). In
contrast to previous works, Kennedy et al. (2017) proposed a double robust estimation
strategy avoiding parametric specification of the dose-response curve.
We contribute to the somewhat less rich literature on robust estimation for categor-
ical and continuous treatments by using an estimation strategy based on covariate bal-
ancing propensity score estimation for inverse probability weighting (e.g., Fong et al. 2018,
Imai & Ratkovic 2014). Fan et al. (2020) recently obtained key results in the binary treat-
ment case by specifying which covariate functions should be balanced for efficient inference:
the propensity score model should be fitted through balancing a set of bases for the out-
come models in the space spanned by the covariates. We provide corresponding results to
the categorical and continuous treatment cases, hence completes the story. In particular, the
procedures we proposed balance the “most suitable” functions of the covariates when the
propensity score is correctly specified, in the sense that they minimize the variability of the
causal effect estimation. When the propensity score is misspecified and the outcome basis
functions are correct, the procedure looks for an approximate balance by minimizing the
2
squared bias of the resulting estimator. As other recent proposals for the binary treatment
case (Athey et al. 2018, Wang & Zubizarreta 2019, Wong & Chan 2017, Zubizarreta 2015),
the method presented here does not necessarily try to achieve exact balance when this is
not possible, although in practice exact balance can always be targeted by enriching the
assignment model.
For both the categorical and continuous treatment case, the proposed estimators are
shown to be robust, i.e. consistent and asymptotically normal for causal contrasts of interest,
either when the model explaining treatment assignment is correctly specified, or when the
correct set of bases for the outcome models has been chosen and the propensity score model
is sufficiently rich. For the categorical treatment case, we show that the estimator proposed
attains the semiparametric efficiency bound when both the treatment assignment model and
the outcome basis are correctly specified. For the continuous case, the causal parameter
of interest is a function. The latter is not parametrized and the estimators proposed are
shown to have bias and variance of the classical nonparametric order under typical regularity
conditions, hence with a usual bias-variance trade-off.
The rest of the paper is organized as follows. Sections 2 and 3 deal with the categori-
cal and the continuous treatment cases, respectively. In both sections, inverse probability
weighting estimators are introduced, where a working model for the generalized propensity
score is estimated by balancing basis functions for the outcome models. We establish the
theoretical properties of the estimators. Simulation studies are conducted in Section 4 to
illustrate the finite sample performance of our methods. In Section 5, we estimate the dose-
response curve of BMI on the decline in self reported health from baseline to a 9 year follow
up in a population of ages 50 or older. Section 6 concludes the paper, while all proofs are
relegated to the Appendix.
2 Categorical treatments
2.1 Balancing scores and preliminaries on estimation
Consider K + 1 treatments, A = 0, 1, . . . , K, and their respective potential outcomes




i if Ai = k, and Xi ∈ Rd is a vector of pre-treatment covariates. We also assume
ignorability of the treatment assignment, i.e. E(Y ki | Xi, Ai) = E(Y ki | Xi) ≡ m(k,Xi) and
pr(Ai = k | Xi = x) ≡ π0(k,x) > δ > 0 for all k ∈ {0, 1, . . . , K} and all x, where π0(k,x) is
named generalized propensity score in the literature (Imbens 2000).
Let θk ≡ E(Y ki ) for k = 0, 1, . . . , K be the average response to the different treatment
levels. The parameters of interest are typically average causal effects between treatment
levels, i.e. causal contrasts such as θk − θ0, if k = 0 is a treatment level of reference. We
consider a parametric working model π(k,x,β) for π0(k,x), with β ∈ Rp, and vectors of
basis functions, B(k,X) : Rd+1 → Rq, aiming at spanning m(k,x). We assume q does not
depend on k for notational simplicity. Thus, correct specification will imply that there exists
a value β0 with
π(k,x,β0) = π0(k,x), (1)




αTkB(k,x) = m(k,x), (2)
for all k and all x. Misspecification, i.e. situations when (1) or (2) does not hold for any
value of β and α, will also be considered in the sequel. Note that one of the advantages of
the herein studied balancing approach is that the parameter α does not need to be known or
estimated. We hence do not use a subscript 0 on α and m(·) to distinguish true parameter
value and correct model since this will be clear from the context.
For estimating θk under the above assumptions one needs to control for the covariates
Xi by using one or both working models. In particular, π(k,x,β) is a balancing score in
the sense that Xi Ai | π(k,x,β0) under (1) (Rosenbaum & Rubin 1983). Thus, for the










where b(Xi) is a vector valued function of the covariates. Based on the resulting fitted









Two issues arise regarding the above procedure. One is that if the propensity score model
(1) is misspecified then, θ̂k is generally biased. Two is the choice of b(X), which is largely
left unsupervised. Fan et al. (2020) overcome these two issues in the binary case (K = 1),
and proposed an optimal choice for b(X), in the sense that the resulting treatment effect
estimator is consistent when (1) is correct, or when (2) is correct and (1) has sufficient
flexibility, and is efficient if both are correct.
We aim to achieve the same kind of optimality and robustness in the categorical treat-
ment case. Two different estimators may be introduced with different properties, which we
discuss heuristically below, before giving a formal treatment in the next section. The first

















at all k = 1, . . . , K, i.e. a system of qK equations. GMM, as described below, can be used if
qK ≥ p. This balancing condition is motivated by pushing the bias of the contrast estimator
θ̂k − θ̂0 towards zero. In fact, it will be shown that the asymptotic bias of θ̂k − θ̂0 is equal to
E [{I(Ai = k)/π(k,Xi,β)− 1}m(k,Xi)− {I(Ai = 0)/π(0,Xi,β)− 1}m(0,Xi)] .
An alternative to setting the bias of θ̂k− θ̂0 to zero for k = 1, . . . , K, is to directly put the









B(k,Xi) = 0 (5)
at all k = 0, . . . , K, i.e. a system of q(K + 1) equations. We will use GMM allowing for
q(K + 1) ≥ p; see (6) below.
The two choices are not necessarily equivalent. In fact, the former choice allows for
biased estimation of θ̂k with the only aim to estimate the contrast θk − θ0 without bias.
We find that, if θ̂k is indeed biased, then θ̂k − θ̂0 will not be efficient. This is because local
efficiency holds when the the fitted propensity score is correctly specified and its parameters
are consistently estimated, which is not the case when (5) does not hold. Due to this
consideration, below we focus on solving (5) and show that the resulting estimator of θk
5
has, under certain conditions, a robust property and, when all working models are correctly
specified, reaches the asymptotic semiparametric efficiency bound.
2.2 Asymptotic properties
We now establish a robustness property and the asymptotic distribution results of the
estimator in (3), where β is estimated through covariate balancing (5); see Appendix A.1
for proofs. To gain an intuitive understanding of the robustness property, we can verify
that when the propensity score model is correctly specified, i.e. when (1) holds for all k and
all x, β̂ is
√
n−consistent under the standard regularity conditions for GMM estimation
(Newey & McFadden 1994), and π(k,x, β̂) → π(k,x,β0) = π0(k,x) in probability as n
tends to infinity. The consistency is a consequence of
E [{I(Ai = k)/π(k,Xi,β0)− 1}B(k,Xi)] = 0
in combination with the regularity conditions, irrespective of whether a correct basis for the

















as n → ∞. On the other hand, when the outcome model basis is actually correctly specified,
i.e. when (2) holds for all k and x, then the propensity model (1) does not need be correct
as long as (5) has a solution. In such case, β̂ is consistent for some value β∗, hence π(k,x, β̂)

























as n → ∞, where the last equality is the result of (2) and (5).

















and Â(β) ≡ n−1∑ni=1 ∂fi(β)/∂βT. Further, let θ ≡ (θ0, . . . , θK)T,
6
gki(β) ≡ I(Ai = k)Yi/π(k,Xi,β)−E{m(k,Xi)}, gi(β) = {g1i(β), . . . , gKi(β)}T andB(β) ≡








We will use the following regularity conditions.
A0. β∗ is the unique solution of E{fi(β)} = 0.
A1. The variance-covariance matrix V(β∗) has bounded positive eigenvalues.
A2. fi(β) is differentiable with respect to β.
A3. The matrix A(β∗) is bounded and has full column rank.
A4. gi(β) is differentiable with respect to β.
These are classical regularity conditions. Condition A0 requires the existence and unique-
ness of a solution, where the uniqueness can be relaxed to local uniqueness. The existence
requirement is automatic when the π(k,x,β) model is correct. In this case β∗ = β0. It is
also natural and standard when (K+1)q, the number of equations in E{fi(β)} is not larger
than p, the dimension of β, which is achievable through enriching the π(k,x,β) model.
Thus, regardless of whether π(k,x,β) is correctly specified or not, we can always justify
Condition A0.
Theorem 1. Assume that either (1) holds for all k and x, or (2) holds for all k and x.
Then, under regularity conditions A0 to A4, n1/2(θ̂−θ) has asymptotic normal distribution
with mean zero and variance
Σ = B(β∗){A(β∗)TV(β∗)−1A(β∗)}−1B(β∗)T +C(β∗)
−B(β∗){A(β∗)TV(β∗)−1A(β∗)}−1A(β∗)TV(β∗)−1D(β∗)
−D(β∗)T[B(β∗){A(β∗)TV(β∗)−1A(β∗)}−1A(β∗)TV(β∗)−1]T,
where C(β∗) ≡ E{gi(β∗)⊗2} and D(β∗) ≡ E{fi(β∗)gi(β∗)T}.
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Theorem 1 highlights a robust property. On the one hand, if the propensity score is
correctly specified then we will have a consistent estimator of the treatment contrast even if
the outcome basis is misspecified. On the other hand, we can also afford to misspecify the
propensity score model, provided that the outcome basis functions are correctly specified. In
the latter case, Condition A0 plays a pivotal role and it is crucial to ensure it. An example
is to use the model π(k,x,β) = βT(k)B(k,x), k = 0, . . . , K, with β = (β
T
(0), · · · ,βT(K))T so
that β has length p = q(K + 1). Then (5) is the derivative of the loss function
n∑
i=1
[I(Ai = k)log{βT(k)B(k,Xi)} − βT(k)B(k,Xi)], (7)
for k = 0, . . . , K, hence the minimizer is a root of (5). The utilization of the same basis
of functions for both nuisance models is used in Wang & Zubizarreta (2019) as well. To
further accommodate one’s favorite propensity model, we can also make linear combination
of this model and any candidate model in mind.
The asymptotic variance simplifies greatly when all models are correctly specified, and
a local efficiency result is obtained.
Corollary 1. Assume that (1) and (2) hold for all k and x and let var(Y ki | Xi) = v(k,Xi).
Then, under the regularity conditions of Theorem 1, n1/2(θ̂ − θ) has asymptotic normal









































+E ([m(k,Xi)− E{m(k,Xi)}][m(l,Xi)−E{m(l,Xi)}]) .
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Remark 1. The variance Σ may be estimated without knowing nor estimating α, by approx-
imating the original definitions of the matrices involved, i.e. B(β0) ≡ E{∂gi(β0)/∂β0T}
and C(β0) ≡ E{gi(β0)⊗2}, instead of the expression involving m(·) and v(·) given in Corol-
lary 1.
Corollary 2. Under the assumptions of Corollary 1, the variance of θ̂ attains the semi-
parametric efficiency bound Σeff , where the (k, l) entry of Σeff is
Σeff,k,l = I(k = l)E{v(k,X)/π(k,X)}+ E([m(k,X)−E{m(k,X)}][m(l,X)−E{m(k,X)}]).
3 Continuous treatments
3.1 Balancing scores and preliminaries on estimation
We now consider a continually valued treatment A, say taking values a in [0, 1]. In this
case, it is reasonable to assume that the potential outcome Y a changes with a smoothly.
We write Y a as Y (a) in a more conventional notation. Note that the observed outcome
for the ith observation, Yi, is assumed to be Yi(ai) when we observe Ai = ai. We observe
a random sample (Ai, Yi,Xi), i = 1, . . . , n, where Xi ∈ Rd is a vector of pre-treatment
covariates observed for all units. Following the literature convention, we assume ignorability
of the treatment assignment, in the sense that E{Yi(a) | Xi, Ai} = E{Yi(a) | Xi}, and the
generalized propensity score is the conditional probability density function of the continuous
treatment Ai given the covariates Xi: π0(a,x) ≡ fA|X(a,x) > δ > 0 for all a ∈ [0, 1] and all
x. We write the expected conditional potential outcome as m(a,x) ≡ E{Yi(a) | Xi = x}.
In such case, the parameter of interest is the treatment response function or the dose-
response function, denoted as θ(a) = E{Yi(a)} for a ∈ [0, 1]. The average causal effects
between two treatment doses, say a and b are obtained by taking their contrast θ(a)− θ(b).
We consider a parametric working model π(a,x,β) for the propensity score π0(a,x), where
β ∈ Rp, and consider a set of basis functions B(a,x) : Rd+1 → Rq aiming at spanning
m(a,x). Thus, correctly specified situations will be such that there exists β0 so that
π(a,x,β0) = π0(a,x), (8)
9
and there exists α such that
αTB(a,x) = m(a,x), (9)
for all a ∈ [0, 1] and all x. Misspecification, i.e. situations where one of (8) and (9) does
not hold, will be allowed in the sequel.

















for two arbitrary a, b values in [0, 1]. Following the same considerations as in Section 2, we








B(a,Xi) = 0 (10)
at all a ∈ [0, 1]. Here, Kl(·) = l−1K(·/l), where K(·) is a kernel function and l is a
bandwidth. Practically, we propose to solve (10) at a set of chosen a values, typically those



















with respect to β to get β̂. Once we obtain β̂, we estimate the causal parameter θ(a) with







for any a within the range of observed values for Ai. Here, h is a bandwidth.
Remark 2. The nonparametric estimator (12) can be viewed as an approximation of
n−1
∑n
i=1 YiKh(Ai − a)/π(Ai,Xi, β̂)
n−1
∑n
i=1Kh(Ai − a)/π(Ai,Xi, β̂)
,









Thus, we can understand (12) as a weighted local constant estimator of θ(a). Similar to the
generalization from local constant to local polynomial estimators in nonparametrics, we can





{Yi − c0 − c1(Ai − a)}2Kh(Ai − a)
π(Ai,Xi, β̂)
,
we can obtain the weighted local linear estimator of θ(a).
3.2 Asymptotic properties
We now study the limiting properties of the estimator (12) using (11); see Appendix A.2 for
proofs. Denote by β∗ the probability limit of β̂. If model (8) is correct, β∗ = β0, otherwise


















with respect to β. Here Ej means taking expectation of the jth observation. We list the
following regularity conditions.









C1. The kernel function K(·) ≥ 0 is bounded, twice differentiable with bounded first deriva-




C2. The bandwidth l satisfies nl4 → 0 and nl2 → ∞. The bandwidth h satisfies h → 0
and nh → ∞.
C3. The basis function B(a,x) is bounded.
C4. The propensity score π(a,x,β) is differentiable with respect to β and a, is bounded
away from zero, and its derivative with respect to a is bounded.
C5. m(a,Xi) is bounded, twice differentiable with respect to a, and the first derivative is
bounded.
C6. σ2(Ai,Xi) ≡ var(Yi | Ai, Xi) is bounded.
11
These are typical regularity conditions. Similar to Condition A0 in the categorical treat-
ment case, the uniqueness requirement in Condition C0 can be relaxed to local unique-









= 0 for j = 1, . . . , n, which is easier to fullfil. The existence
of β∗ is guaranteed when the propensity model π(a,x,β) is correctly specified, and is a
standard requirement when the number of equations qn is not larger than the length of β.
Thus, in the situation where we are not confident that a correct propensity model is used,
we can always enrich the model to accommodate Condition C0. We start by giving the
convergence rate of β̂.
Lemma 1. Denote by β∗ the probability limit of β̂. If model (8) is correct, β∗ = β0,
otherwise β∗ is the value that minimizes (13). Under regularity conditions C0 to C4, β̂ −
β∗ = Op(n
−1/2).
Condition C0 is not really necessary for Lemma 1. We can redefine β∗ as the unique
minimum of (13) and Lemma 1 still holds. Because the nonparametric estimation conver-
gence rate is slower than Op(n
−1/2), Lemma 1 indicates that we can fix β at β∗ in the
following analysis as long as we let nl4 → 0, and the first order bias and variance property
of θ̂(a) will not be affected.
Theorem 2. Under regularity conditions C0 to C6, and if (8) holds, then the estimator
θ̂(a) defined by (12) has asymptotic normal distribution with asymptotic bias and variance:




















where σ2(Ai,Xi) = var(Yi | Ai,Xi).
Theorem 3. Under regularity conditions C0 to C6, and if (9) holds, then the estimator
θ̂(a) defined by (12) has asymptotic normal distribution with asymptotic bias and variance:






















Theorems 2 and 3 together reflect a robust property of the proposed estimator, and give
equivalent results when all nuisance models are correctly specified. Specifically, Theorem 2
describes the robustness to misspecification of the outcome models, in that as long as the
propensity score is correctly specified, the estimation of the treatment response function is
valid even if we do not assume a correct model for the outcome. This is because the propen-
sity score balances any functions of the covariates. Theorem 3 allows for the misspecification
of the propensity score, with the restriction that Condition C0 needs to hold. If we choose
to ensure C0 through allowing sufficiently many model parameters, then β will have length
p = qn, which practically means that the propensity score is non-parametrically estimated.
For example, we can let π(aj ,x) = β
T
(j)B(aj,x), where β(j) has dimension q. Then, solving
(10) for all observed a = aj corresponds to minimizing the loss function
n∑
i=1
[Kl(Ai − aj)log{βT(j)B(aj,Xi)} − βT(j)B(aj ,Xi)],
for j = 1, . . . , n.
Finally, note here, that the dose response function θ(a) is estimated nonparametrically,
and this estimation has bias of order h2, although asymptotically vanishing, and there is the
usual bias-variance trade-off. Next, we give a result useful for inference on a causal contrast
θ(a)− θ(b).
Theorem 4. Under regularity conditions C0 to C6, and if either (8) or (9) hold, then































where c ≡ (a− b)/h.
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Note that when c /∈ (−2, 1), K(t)K(t + c) = 0 for all t. Therefore, the covariance has
order O(n−1) if c /∈ (−2, 1) and O{(nh)−1} otherwise. Thus, comparing the term of order
O{(nh)−1} in the covariance in Theorem 4 with the terms of the same order for the variances
in Theorems 2 and 3, we see that when a and b are close to each other relative to h, the
variance of the contrast θ̂(a)− θ̂(b) is close to zero. On the contrary, when a and b are far
apart, then the variance of the contrast is dominated by the variance of θ̂(a) and θ̂(b).
Theorems 2, 3 and 4 provide theoretical properties of the leading orders of the bias,
variance and covariance properties of the nonparametric estimators. In large samples, these
results can be used to perform inference. Practically, unlike for parameter estimation,
because the next order of the nonparametric analysis is only slightly smaller than the leading
order, inference based on these results is often not sufficiently precise. This phenomenon has
been observed in many nonparametric or even semiparametric problems including quantile
regression, survival analysis, etc., and bootstrap is often used instead.
4 Simulation Experiments
4.1 Categorical treatment
To investigate the finite sample performance of our method for the categorical treatment
case, we performed a first simulation study. We generate a five dimensional covariate vector
X, where X1 = 1, and X2 to X5 are generated independently from a normal distribu-




Tβk)} for k = 0, 1, 2, and let π0(3, x) = 1 −
∑2
k=0 π0(k, x).
Here, β0 = (0,−0.2475,−0.275, 0.1875, 0.075)T, β1 = (0,−0.165,−0.15, 0.125, 0.05)T, and
β2 = 0. We set m(k,x) = α
T
k x, where α0 = (200, 0, 13.7, 13.7, 13.7)
T, and α1 to α3 are set
to be (200, 27.4, 13.7, 13.7, 13.7)T. We generated Y ki ’s by adding a standard normal random
noise to the true mean m(k,xi).
In implementing the estimators, in addition to the ideal case where both the π(·) model
and the basis for the m(·) model are correct, we also experiment with incorrectly specified
models. In misspecifying the π(·) models, we replace X1 with eX1 , X2 with X1X2, X3 with
X21X3, X4 with X1 + X4 and X5 with X5 sin(X5)
2. In misspecifying the m(·) models, we
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replace X1 with X
2
1 , X2 with X1X2, X3 with X2X
2
3 andX4 with (X4−3)3+3. We investigate
four different scenarios, when both models are correct, when the π(·) model is misspecified,
when the m(·) model is misspecified and when both models are misspecified. Note that our
design is such that correctly specifying the basis for m(·) corresponds to balancing the first
moments of the covariates. For comparison, we also implemented the inverse probability
weighting estimators (IPW) using maximum likelihood for the estimation of the propensity
score, and its double robust augmented version using both the correct propensity score and
outcome models; for the latter we use the R-package PSweight (Zhou et al. 2020). The
results over 1000 replicates are displayed in Tables 1-3 (see Appendix A.7) for different
sample sizes, where for each causal contrast θk − θ0, k = 1, 2, 3, we provide bias, standard
deviation, mean squared errors (MSE) as well as average estimated standard deviation,
and empirical coverage of the resulting 95% confidence interval. See Remark 1 for how the

























































mT.piT mT.piF mF.piT mF.piF IPW DR
Estimators
sd
Figure 1: Absolute bias and sd for the three contrasts θj−θ0, j = 1, 2, 3, over 1000 replicates
for the six estimators: m, π correct (mT.piT), m correct (mT.piF), π correct (mF.piT), m, π
misspecified (mF.piF), IPW and augmented IPW (DR), and three sample sizes.
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Biases and standard deviations are also displayed graphically in Figure 1. These numeri-
cal experiments confirm the theoretical robustness properties in the sense that much smaller
biases are observed when at least one of the models is correctly specified compared to when
both models π(·) and m(·) are misspecified. Increasing sample sizes improves biases and
variances as expected, except when all models are misspecified. Moreover, compared to the
maximum likelihood based inverse probability weighting method (ML-IPW), our estimator
yields lower variance, and its MSE is smaller even when both models are misspecified. The
classical augmented IPW (DR) should be considered as a benchmark, since in contrast with
our estimator which only fits the propensity score, DR fits all models. Fitting the outcome
models is, however, arguably not desirable (Rubin 2007), and it appears to yield lower finite
sample bias and variance in the cases considered. The relative efficiency of our estimator
compared to DR improves with increasing sample sizes although slowly. Empirical coverages
match the nominal level of 95%, and this gets better with increasing sample size, except for
when all models are misspecified as expected from theory.
4.2 Continuous treatments
To assess the performance of the proposed methods under continuous treatment, we exper-
iment with both linear and nonlinear outcome models. In the nonlinear design, we generate
a five dimensional covariate vector X, where X1 = 1 and (X2, X3, X4, X5)
T follows a mul-
tivariate standard normal distribution. Thus, these covariates have mean zero, variance 1












Note that this is the probability density function of A when A/20 follows a beta distribution
with parameters 15λ(x) and 15{1− λ(x)}, where logit{λ(x)} = (−0.8, 0.1, 0.1,−0.1, 0.2)x.
We further generate the response Y from a Bernoulli distribution with probabilitym1(A,X) ≡
expit{µ(A,X)}, where µ(a,x) = (1, 0.2, 0.2, 0.3,−0.1)x + a(0.1,−0.1, 0, 0.1, 0)x − 0.133a3.
This simulation design is identical to that of Kennedy et al. (2017). In the linear design, the
response is generated from a normal distribution with mean m2(A,X) and variance 0.16,
where m2(a,x) = {µ(a,x) + 15}/20.
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Two different types of IPW estimators are implemented in both linear and nonlinear
outcome cases, respectively a maximum likelihood based inverse probability weighting esti-
mator and the proposed robust balancing estimator. For the former, we used a maximum
likelihood approach to estimate the parameter of the propensity score. For the balancing
estimator, (11) is minimized where the bandwidth l was set to 3n−1/3. In the nonparamet-
ric estimation of θ(a) in (12), both the local constant and local linear estimators given in
Remark 2 are implemented and h was selected by the leave-one-out cross-validation and
the one-sided cross-validation (Hart & Yi 1998). For comparison, the inverse probability
weighted and the doubly robust estimator given in Kennedy et al. (2017) are also imple-
mented using the R-package npcausal (github.com/ehkennedy/npcausal).
For the linear outcome case, the estimators are assessed in four different scenarios where
both models are correct or either of the models is misspecified. We use the basis of µ(a,x)
as basis of the outcome model. In misspecifying either the π(·) or m(·) model, we replaced






+ 10, (x2x4/25 + 0.6)




In addition, the misspecified mi(·) (i = 1, 2) has no cubic term of a in its bases. We in fact
used the same construction for the nonlinear outcome model. However, we point out that
this leads to the scenario that the outcome model basis is never correctly specified, while
the propensity score model is either correct or incorrect.
We generated the simulated data with sample sizes n = 500, 1000, 2000 and the result
is based on 1000 replicates. Figure 2 illustrates the simulated data with the nonlinear
outcome model and the empirical coverage of the proposed estimator under n = 1000. We
assessed the performance of each estimator by calculating the integrated absolute bias and














where A∗ is a trimmed support of A which excludes 10% mass on the boundaries.
17


















Figure 2: Simulation in the continuous nonlinear outcome case. Rug: One simulated data




using local constant estimation and CV, and T = 1000; Filled curves: 5% and 95% quantiles
of θ̂t(a).
The results are given in Tables 4 and 5 (Appendix A.7). The integrated absolute bias and
the integrated RMSE are numerically calculated and presented with the integrated RMSE
in parentheses. For ease of presentation, both measures are multiplied by 100. These results
confirm that the proposed estimator is robust. In addition, as seen in Table 4, we find that
our estimator shows robust performance even under the nonlinear outcome design where (9)
does not hold, which means that none of the four cases used the true basis of the outcome
model. Among the balancing estimators, the variant using local linear fit and one-sided
CV seems to perform best in terms of bias and RMSE when both all nuisance models are
correctly specified. The balancing method has also both lower bias and RMSE than the IPW
estimators. We note that the bias is most sensitive to specification of the propensity score
model. In all cases, the proposed estimator outperforms the estimator by Kennedy et al.
(2017) in terms of bias, although RMSE Kennedy’s double robust estimator has lowest
RMSE. Here, as for the categorical case, this estimator can be considered a benchmark
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since it fits also outcome models in contrast with the introduced balancing estimators.
5 Effect of BMI on self reported health decline
As a case study, we investigate the effect of Body Mass Index (BMI) on self reported
health (SRH) decline. This analysis is based on data from the Survey of Health, Aging
and Retirement in Europe (SHARE). This is an interview based longitudinal survey of
individuals of age 50 years or older (Börsch-Supan et al. 2013). Here we use data on women
from three countries (Sweden, Netherland, Italy) that participate in waves 1 and 5 of the
SHARE study. Wave 1 data collected in 2004 serve as the baseline, and individuals are
followed up at wave 5, collected in 2013. We are interested in estimating the average causal
effect of BMI (a continuous valued treatment with range 15.62-49.60 in the data) on SRH
decline between baseline and follow-up. SRH is measured by asking the question “Would
you say your health is: excellent, very good, good, fair or poor?” Despite its unspecific
nature, SRH has been found to predict mortality well in many studies (Idler & Benyamini
1997), and is thus considered as an important health indicator. SRH decline is here defined
as a binary variable which, for the respondents reporting “excellent, very good, or good
health” at baseline, will take value one if they changed their answer to “fair or poor health”
at follow-up, and 0 otherwise. The resulting sample of complete cases consists of 1530
participants. In Genbäck et al. (2018), predictors of SRH decline were investigated using
logistic regression, and it was found that BMI measured at baseline was a significant (5%
level) predictor of SHR decline. Here we aim at sharpening this analysis and study whether
there is evidence that BMI is a causal agent of SRH decline by using the introduced covariate
balancing procedure for causal inference. The covariates observed at baseline that we use
for balancing are age (years), whether the participant responded to the SRH question at the
beginning of the interview (or the end), socio-economic variables (education level, make ends
meet easily), cognitive function variables (numeracy test, date orientation question), health
variables (number of chronic diseases, number of mobility problems, depression measure,
maximum grip strength, limitation in normal activities), and lifestyle variables (smoking
habits, alcohol usage, physical activities). We refer to Genbäck et al. (2018) for a detailed
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description of these covariates. Encouraged by Afshin, A. et al. (2017) and Ng et al. (2016),







β = (γ, φ).
The basis functions for the outcome model are chosen to be B(a,x) = (x, a, a2, a3). A value
for β(0) = (γ(0), φ(0)) is obtained by the maximum likelihood estimation and used as the
starting value for solving the balancing equations (11), with the bandwidth l = 6n−1/3. For
nonparametric estimation of θ(a) in (12), the local constant estimator given in Remark 2 is
used for simplicity, where h was selected by one-sided cross-validation (Hart & Yi 1998).


















Figure 3: Effect of BMI on SRH decline. Rug plot: the observations; solid line: the estimated
average treatment effect curve; filled gray curve: the estimated pointwise confidence band.
Figure 3 displays the estimated effect curve of BMI on SRH decline. Confidence bands
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are obtained using the variance estimates described in Appendix A.2.4. Overall, we observe
a nonlinear effect curve. Specifically, we observe that BMI has no significant effect for values
of BMI considered as normal (i.e. below 25) in that the confidence band of the probability
of decline contains the flat line. However in the range of BMIs considered as overweight
(BMI larger than 25), an increase in the probability of SRH decline is observed, reflecting
the causal effect of the increase of BMI on the probability of SRH decline. The causal
interpretation of this effect relies on the assumptions made. Mainly that all confounders
have been observed, and that a well defined intervention on BMI corresponds to the effect
measured (Hernan & Taubman 2008). Nevertheless, the results are in line with earlier
studies pointing at a wide range of health risks from overweight and obesity (Afshin et al.
2017).
6 Discussion
We have introduced novel robust estimation and inference tools for multi-level treatments.
For continuous treatments our proposal together with that of Kennedy et al. (2017) are, to
the best of our knowledge, the only robust methods which model the causal dose-response
curve nonparametrically. Our results expand the recent important developments given by
Fan et al. (2020). For both the categorical and continuous treatment cases, we achieve
robustness by balancing basis functions for the outcome models when fitting a generalized
propensity score model which is either correct or sufficiently rich. While the estimator
proposed is locally efficient for the categorical case, asymptotic efficiency is not relevant for
the continuous case where the parameter of interest is a function of the dose and is estimated
non-parametrically.
The proposal differs from earlier double robust estimation in that it does not need
outcome models to be fitted. This is an advantage when outcome is not observed at the
design stage of the study. Indeed, it is argued that observational studies should be designed
without using observed outcomes even if available in order to mimic the “objectivity” of
the designs of randomized trials; see (Rubin 2007) for a detail discussion. Our simulation
results indicate that this is done at a cost in finite sample performance. Our work is
21
somewhat in contrast to the widespread practice of using simple (e.g. linear or logistic
linear) models for the propensity score with matching estimators assuming that balance in
the joint distribution of the covariates is achieved (e.g., Rubin & Thomas 2000, Waernbaum
2010). However, balancing the joint distribution is not necessary, and in exchange, more
elaborate requirements are on the propensity score. From the results presented herein, it
becomes transparent which functions of the covariates are sufficient to balance for in order
to both obtain consistency and, in the categorical treatment case, local efficiency.
In high-dimensional settings (d ≈ n), it has recently been shown that bias due to regu-
larization in estimating correctly specified linear outcome models can be corrected by using
relevant weights which are not necessarily based on the true propensity score (Athey et al.
2018); see also, e.g., Farrell (2015) and Dukes et al. (2020) for double robust estimation with
many covariates. An interesting future direction of research is whether one can generalize
the results presented herein to high-dimensional situations, balancing many basis functions
for the outcome models by using, e.g., regularized GMM techniques (Belloni et al. 2018).
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Appendix
A.1 Categorical treatment: derivations



























i=1 fi(β)}, is such that





When (1) holds β∗ = β0.






























∗)}+A(β∗)TV(β∗)−1A(β∗)n1/2(β̂ − β) +Op(n−1/2),
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Proof of Theorem 1. Using Lemma 2 we can write























When either (1) and/or (2) hold, we already know that E{gi(β∗)} = 0. Thus, under
regularity conditions,
√









where C(β∗) ≡ E{gi(β∗)⊗2} and D(β∗) ≡ E{fi(β∗)gi(β∗)T}.



















































and A(β0) = {A1(β0)T, . . . ,AK(β0)T}T, B(β0) = {B1(β0)T, . . . ,BK(β0)T}T, V(β0) =
{Vkl(β0)}Kk,l=1, C(β0) = {Ckl(β0)}Kk,l=1, D(β0) = {Dkl(β0)}Kk,l=1.
Note that αTAk(β0) = Bk(β0) andVkl(β0)α = Dkl(β0), so (IK+1⊗αT)A(β0) = B(β0)
andV(β0)(1K,K⊗α) = D(β∗). Thus, Σ = C(β0)−B(β0){A(β0)TV(β0)−1A(β0)}−1B(β0)T.
Proof of Corollary 2. Here we have set the dimension of fi(β) to be the same as the dimen-
sion of β hence we can solve
∑










∗) +A(β∗)n1/2(β̂ − β) +Op(n−1/2),
hence



























































































































i.e., the (k, l) entry of Σ is






Compared to the semiparametric efficiency bound obtained in Section A.1.2 below, we see
that the estimator is asymptotically efficient.
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A.1.2 Semiparametric efficiency bound
The original model can be written in general as
fX,A,Y (x, a, y) = fX(x)
K∏
k=0
[π(k,x)fǫ|(A,X){y −m(k,x), k,x}]I(a=k), (19)
where π(k,x) satisfies 0 < π(k,x) < 1,
∑K
k=0 π(k,x) = 1 and fǫ|(A,X){y − m(k,x), k,x}
satisfies
∫
fǫ|(A,X)(ǫ, k,x)dǫ = 1 and
∫
ǫfǫ|(A,X)(ǫ, k,x)dǫ = 0 for all k = 0, . . . , K. The
parameter of interest is θ = (θ1, . . . , θK)
T, where θk = E{m(k,X)}. Here, we sometimes
write ǫ = y −m(a,x) for convenience. Consider an arbitrary parametric submodel















































The tangent space of (19) is T = T ζ + T β + T α + T γ , where
T ζ = [a(X) : E{a(X)} = 0],












T γ = [a(ǫ, A,X) : E{a(ǫ, A,X) | A,X} = 0, E{ǫa(ǫ, A,X) | A,X} = 0].
30
The parameter of interest in the submodel is









































Denote φ̃k = I(A = k)
Y−m(k,X)
π(k,X)











































































































Hence E(φSTβ) = 0 and E(φS
T










































∂fǫ|(A,X){Y k −m(k,X,α), k,X,γ}/∂{Y k −m(k,X,α)}











































where α, ζ are evaluated at the true value α0, ζ0. Therefore,
E(φSTζ ) = [E{m(0,X)Sζ(X, ζ)}, . . . , E{m(K,X)Sζ(X, ζ)}]T = ∂θ(ζ,β,α,γ)/∂ζT.
and
E(φSTα) = [E{∂m(0,x,α)/∂α}, . . . , ∂E{m(K,x,α)/∂α}]T = ∂θ(ζ,β,α,γ)/∂αT.
Thus, φ satisfies E(φSTδ ) = ∂θ(δ)/∂δ
T. Because the submodel is arbitrary, φ is an influence
function of θ. We now try to obtain Π(φ | T ) so we can obtain the efficient influence
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and c = [E{m(0,X)}, . . . , E{m(K,X)}]T, where v(k,X) ≡ var(Y k | X, A = k). We can
verify that φ1 ∈ T γ , φ2 ∈ T α, and φ3 ∈ T ζ, while c is a constant. Then φ − c is the
efficient influence function. Thus, the efficient variance is Σeff = var(φ), where the (k, l)
entry of Σeff is
Σeff,k,l = I(k = l)E{v(k,X)/π(k,X)}+ E([m(k,X)−E{m(k,X)}][m(l,X)−E{m(k,X)}]).
When K = 1, this agrees with the special case corresponding to the binary treatments
(Hahn 1998), and when K > 1, with earlier results (Cattaneo 2010).
A.2 Continuous treatment: derivations
We prove all results under a general weight function w(Aj), where w(Aj) =
∑n
i=1Kl(Ai−Aj)
in the main paper.
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A.2.1 Convergence rate of β̂















































































































































































































































































































































































































also due to the definition of β∗. Thus, as long as nl4 → 0, β̂ − β∗ = Op(n−1/2).
A.2.2 Robustness and asymptotic bias and variance
Proof of Theorem 2. When model (8) holds, we can easily check that the expectation of the













































Thus, because the nonparametric estimation convergence rate is slower than Op(n
−1/2), by
Lemma 1 we can fix β at β0 in the following analysis, and the first order bias and variance
property of θ̂(a) will not be affected.
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+O(n−1h + n−1 + n−1h−1/2).
The asymptotic normality is shown in Section A.2.3 below.
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+O(n−1h+ n−1 + n−1h−1/2).
40
The asymptotic normality is shown in Section A.2.3 below.




































































































When a and b are sufficiently close, so that c ≡ (a− b)/h ∈ (−2, 1), we have
E
{



































































Note that when c /∈ (−2, 1), K(t)K(t+ c) = 0 for all t /∈ [−1, 1] hence the above expression






























The asymptotic normality is shown in Section A.2.3 below.
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A.2.3 Asymptotic distribution of θ̂(a)













































































converges to a normal distribution with mean zero and variance nhvar{θ̂(a)}.
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Consider an arbitrary linear combination
∑J















































converges to a normal distribution with mean zero. To compute its variance, we compute
cov{θ̂(a), θ̂(b)} for arbitrary a, b below.





























Here c = (a − b)/h. Then the above analysis leads to that θ̂(a) − θ(a) is asymptotically a























+O(n−1 + n−1h+ n−3/2h−1).
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A.7 Simulation results: Tables
Table 1: Results based on 1000 replicates for the estimation of contrasts θk − θ0,k = 1, 2, 3
with balancing estimator proposed using model π(·) and basis of m(·), which are either
correctly specified or misspecified. Last blocks contain maximum likelihood based IPW
(ML-IPW) and augmented IPW (DR) estimators. Sample size n = 500.
θk − θ0 bias sd MSE ŝd 95%
m, π correct
k = 1 0.3160 2.6185 6.9566 2.6078 0.9520
k = 2 0.3211 2.6183 6.9586 2.6073 0.9510
k = 3 0.3167 2.6173 6.9503 2.6075 0.9520
π correct
k = 1 1.3666 7.4357 57.1567 6.2238 0.9110
k = 2 1.2198 7.1377 52.4345 5.7876 0.8940
k = 3 1.3181 7.0207 51.0281 5.7158 0.9000
m correct
k = 1 2.1145 3.4709 16.5182 3.5342 0.9550
k = 2 2.1204 3.4748 16.5701 3.5341 0.9560
k = 3 2.1154 3.4711 16.5235 3.5339 0.9530
m, π misspecified
k = 1 3.2163 7.8904 72.6030 7.0024 0.9150
k = 2 3.0839 7.6868 68.5982 6.5804 0.9020
k = 3 3.1900 7.4916 66.3006 6.5237 0.9060
ML-IPW, π correct
k = 1 0.0842 16.5578 274.1668 16.3236 0.9650
k = 2 0.4053 14.3483 206.0379 14.0882 0.9530
k = 3 0.1948 14.0600 197.7213 14.0238 0.9520
DR, m, π correct
k = 1 0.040 2.352 5.533 2.451 0.962
k = 2 0.045 2.351 5.529 2.450 0.962
k = 3 0.041 2.349 5.520 2.450 0.964
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Table 2: Results based on 1000 replicates for the estimation of contrasts θk − θ0,k = 1, 2, 3
with balancing estimator proposed using model π(·) and basis of m(·), which are either
correctly specified or misspecified. Last blocks contain maximum likelihood based IPW
(ML-IPW) and augmented IPW (DR) estimators. Sample size n = 1000.
θk − θ0 bias sd MSE ŝd 95%
m, π correct
k = 1 0.1233 1.9123 3.6720 1.8477 0.9380
k = 2 0.1273 1.9111 3.6686 1.8472 0.9370
k = 3 0.1233 1.9092 3.6604 1.8471 0.9380
π correct
k = 1 0.3756 5.1489 26.6518 4.4066 0.9160
k = 2 0.4287 4.7061 22.3316 4.0946 0.9070
k = 3 0.3302 4.7935 23.0868 4.0950 0.9110
m correct
k = 1 1.2285 2.2205 6.4397 2.2226 0.9360
k = 2 1.2325 2.2225 6.4588 2.2222 0.9350
k = 3 1.2284 2.2206 6.4400 2.2220 0.9360
m, π misspecified
k = 1 1.4565 5.4090 31.3788 4.6882 0.9080
k = 2 1.5062 4.9498 26.7694 4.3911 0.9050
k = 3 1.4004 5.0466 27.4296 4.3925 0.9150
ML-IPW, π correct
k = 1 0.0974 11.5132 132.5634 10.8010 0.9540
k = 2 0.2635 10.2896 105.9450 9.4923 0.9510
k = 3 0.0573 10.4489 109.1838 9.4719 0.9480
DR, m, π correct
k = 1 0.048 1.747 3.056 1.737 0.947
k = 2 0.052 1.747 3.054 1.736 0.947
k = 3 0.048 1.746 3.050 1.736 0.949
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Table 3: Results based on 1000 replicates for the estimation of contrasts θk − θ0,k = 1, 2, 3
with balancing estimator proposed using model π(·) and basis of m(·), which are either
correctly specified or misspecified. Last blocks contain maximum likelihood based IPW
(ML-IPW) and augmented IPW (DR) estimators. Sample size n = 2000.
θk − θ0 bias sd MSE ŝd 95%
m, π correct
k = 1 0.0147 1.2971 1.6826 1.3063 0.9490
k = 2 0.0147 1.2972 1.6830 1.3059 0.9510
k = 3 0.0125 1.2972 1.6830 1.3059 0.9520
π correct
k = 1 0.1837 3.5871 12.9007 3.2328 0.9310
k = 2 0.1936 3.3857 11.5003 3.0257 0.9220
k = 3 0.1522 3.3617 11.3241 3.0269 0.9310
m correct
k = 1 0.7568 1.4234 2.5987 1.4744 0.9450
k = 2 0.7566 1.4232 2.5980 1.4740 0.9460
k = 3 0.7541 1.4243 2.5975 1.4740 0.9460
m, π misspecified
k = 1 0.9441 3.6714 14.3704 3.3614 0.9190
k = 2 0.9392 3.4964 13.1066 3.1605 0.9140
k = 3 0.8885 3.4607 12.7659 3.1639 0.9290
ML-IPW, π correct
k = 1 -0.0998 7.1859 51.6464 7.2091 0.9460
k = 2 0.1173 6.3511 40.3504 6.3572 0.9460
k = 3 0.1109 6.3369 40.1689 6.3598 0.9420
DR, m, π correct
k = 1 -0.006 1.208 1.459 1.229 0.962
k = 2 -0.006 1.209 1.461 1.228 0.958
k = 3 -0.008 1.208 1.460 1.228 0.959
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Table 4: Results based on 1000 replicates for continuous treatment case, and nonlinear
outcome model. Integrated absolute bias and integrated RMSE (in parentheses). ML-IPW
is the maximum likelihood based IPW estimator and CB-IPW the robust balancing-IPW
method proposed (11-12).
n = 500
π,m correct π correct m correct none correct
IPW of Kennedy na 3.33 (4.95) na 3.00 (4.81)
DR of Kennedy 1.09 (3.31) 2.05 (3.75) 1.07 (3.31) 2.55 (4.02)
π correct none correct
ML-IPW
Constant, CV na 0.52 (4.52) na 1.21 (4.40)
Constant, OSCV na 0.39 (4.23) na 1.49 (4.42)
Linear, OSCV na 0.40 (4.08) na 1.99 (4.45)
CB-IPW
Constant, CV 0.38 (4.24) 0.26 (4.32) 1.15 (4.18) 1.23 (4.25)
Constant, OSCV 0.28 (4.05) 0.31 (4.18) 1.41 (4.26) 1.52 (4.35)
Linear, OSCV 0.69 (3.91) 0.82 (4.09) 1.86 (4.22) 1.99 (4.34)
n = 1000
π,m correct π correct m correct none correct
IPW of Kennedy na 3.15 (4.11) na 2.80 (3.91)
DR of Kennedy 0.97 (2.60) 1.88 (3.16) 0.94 (2.37) 2.36 (3.28)
π correct none correct
ML-IPW
Constant, CV na 0.39 (3.26) na 1.32 (3.30)
Constant, OSCV na 0.46 (2.88) na 1.42 (3.23)
Linear, OSCV na 0.48 (2.80) na 1.96 (3.41)
CB-IPW
Constant, CV 0.27 (3.08) 0.20 (3.15) 1.27 (3.13) 1.34 (3.19)
Constant, OSCV 0.29 (2.78) 0.20 (2.89) 1.37 (3.08) 1.46 (3.17)
Linear, OSCV 0.68 (2.72) 0.69 (2.88) 1.85 (3.20) 1.97 (3.32)
n = 2000
π,m correct π correct m correct none correct
IPW of Kennedy na 3.02 (3.62) na 2.65 (3.44)
DR of Kennedy 0.79 (1.83) 1.76 (2.58) 0.78 (1.81) 2.37 (3.82)
π correct none correct
ML-IPW
Constant, CV na 0.33 (2.44) na 1.45 (2.76)
Constant, OSCV na 0.56 (2.09) na 1.41 (2.57)
Linear, OSCV na 0.54 (1.97) na 2.00 (2.89)
CB-IPW
Constant, CV 0.22 (2.30) 0.19 (2.43) 1.41 (2.59) 1.47 (2.66)
Constant, OSCV 0.39 (1.95) 0.26 (2.12) 1.36 (2.39) 1.44 (2.49)
Linear, OSCV 0.66 (1.91) 0.70 (2.15) 1.91 (2.68) 2.00 (2.81)
Note: “na” stands for “not applicable”.
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Table 5: Results based on 1000 replicates for continuous treatment case, and linear outcome
model. Integrated absolute bias and integrated RMSE (in parentheses). ML-IPW is the
maximum likelihood based IPW estimator and CB-IPW the robust balancing-IPW method
proposed (11-12).
n = 500
π,m correct π correct m correct none correct
IPW of Kennedy na 3.02 (5.31) na 2.58 (4.02)
DR of Kennedy 0.58 (2.60) 0.72 (2.69) 0.64 (2.55) 0.90 (2.64)
ML-IPW
Constant, CV na 0.26 (3.55) na 0.28 (3.55)
Constant, OSCV na 0.07 (3.64) na 0.55 (3.74)
Linear, OSCV na 0.18 (3.36) na 0.68 (3.44)
CB-IPW
Constant, CV 0.23 (3.29) 0.17 (3.34) 0.27 (3.21) 0.29 (3.28)
Constant, OSCV 0.12 (3.55) 0.21 (3.58) 0.53 (3.56) 0.56 (3.58)
Linear, OSCV 0.25 (3.23) 0.33 (3.27) 0.65 (3.26) 0.68 (3.30)
n = 1000
π,m correct π correct m correct none correct
IPW of Kennedy na 2.96 (4.82) na 2.55 (3.33)
DR of Kennedy 0.44 (1.92) 0.62 (1.97) 0.48 (1.85) 0.78 (1.98)
ML-IPW
Constant, CV na 0.29 (2.55) na 0.27 (2.52)
Constant, OSCV na 0.10 (2.52) na 0.46 (2.61)
Linear, OSCV na 0.07 (2.31) na 0.58 (2.43)
CB-IPW
Constant, CV 0.23 (2.34) 0.19 (2.39) 0.26 (2.28) 0.26 (2.32)
Constant, OSCV 0.04 (2.43) 0.05 (2.46) 0.44 (2.46) 0.44 (2.48)
Linear, OSCV 0.15 (2.21) 0.16 (2.27) 0.56 (2.27) 0.56 (2.31)
n = 2000
π,m correct π correct m correct none correct
IPW of Kennedy na 2.93 (3.44) na 2.43 (2.97)
DR of Kennedy 0.41 (1.45) 0.60 (1.55) 0.43 (1.40) 0.75 (1.57)
ML-IPW
Constant, CV na 0.22 (1.84) na 0.32 (1.84)
Constant, OSCV na 0.12 (1.79) na 0.42 (1.85)
Linear, OSCV na 0.09 (1.70) na 0.57 (1.80)
CB-IPW
Constant, CV 0.18 (1.72) 0.15 (1.74) 0.29 (1.66) 0.29 (1.67)
Constant, OSCV 0.08 (1.72) 0.06 (1.76) 0.40 (1.74) 0.40 (1.76)
Linear, OSCV 0.14 (1.61) 0.14 (1.65) 0.54 (1.68) 0.55 (1.71)
Note: “na” stands for “not applicable”.
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